Genomic platforms analyze the DNA and RNA of cancer cells to identify genetic mutations and other alterations. By comparing the genetic profiles of cancerous and normal cells, researchers can pinpoint specific changes that drive cancer growth. This information can be used to develop targeted therapies that specifically attack cancer cells with certain genetic mutations.
